Jonathan Katz, PhD

Assistant Professor of Research Medicine

Is this your profile? Click to edit

Overview

Dr. Katz earned his B.S. in Microbiology & Molecular Genetics and Cognitive Science. He then went on to earn his PhD in Biochemistry and Molecular Biology from University of California, Los Angeles.

Dr. Katz’s research interests include mass spectrometry, proteomics and elucidation of novel clinical prognostic markers.

Publications

Deploying Mass Spectrometric Data Analysis in the Amazon AWS Cloud Computing Environment. Methods Mol Biol. 2021; 2271:375-397.. View in PubMed
Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa160.. View in PubMed
ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness. Cell Death Differ. 2020 06; 27(6):1981-1997.. View in PubMed
Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. Oncogene. 2019 04; 38(16):3003-3018.. View in PubMed
Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2). Oncotarget. 2018 Jun 08; 9(44):27363-27379.. View in PubMed
JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines. Mol Cancer Ther. 2017 08; 16(8):1645-1657.. View in PubMed
Virtualization of Legacy Instrumentation Control Computers for Improved Reliability, Operational Life, and Management. Methods Mol Biol. 2017; 1550:309-324.. View in PubMed
Krüppel-like factors in cancer. Nat Rev Cancer. 2013 Oct; 13(10):701-13.. View in PubMed
A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep. 2013; 3:1449.. View in PubMed
A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol. 2012 Oct; 30(10):918-20.. View in PubMed

Jonathan Katz, PhD

Overview

Publications

Similar People